Patients with Obesity Should be Recognised as a Special Patient Population During Drug Development of Antibacterial and Antifungal Agents; A Call to Action K. P. van RheeC. A. J. KnibbeR. J. M. Brüggemann Current Opinion Open access 05 January 2024 Pages: 1 - 12
Preclinical Pharmacokinetic/Pharmacodynamic Studies and Clinical Trials in the Drug Development Process of EMA-Approved Antifungal Agents: A Review Theresa PechoMarkus Zeitlinger Review Article Open access 16 November 2023 Pages: 13 - 26
A Comprehensive Review of the Clinical Pharmacokinetics, Pharmacodynamics, and Drug Interactions of Nirmatrelvir/Ritonavir Jacqueline GerhartDonna S. CoxBharat Damle Review Article Open access 04 January 2024 Pages: 27 - 42
Interplay of UDP-Glucuronosyltransferase and CYP2C8 for CYP2C8 Mediated Drug Oxidation and Its Impact on Drug–Drug Interaction Produced by Standardized CYP2C8 Inhibitors, Clopidogrel and Gemfibrozil Katsumi IgaAkiko Kiriyama Original Research Article 03 November 2023 Pages: 43 - 56
Pharmacokinetics, Safety, and Tolerability of Anti-SARS-CoV-2 Monoclonal Antibody, Sotrovimab, Delivered Intravenously or Intramuscularly in Japanese and Caucasian Healthy Volunteers Ahmed NaderElizabeth AlexanderDaren Austin Original Research Article Open access 13 November 2023 Pages: 57 - 68
Development of a Generic Fetal Physiologically Based Pharmacokinetic Model and Prediction of Human Maternal and Fetal Organ Concentrations of Cefuroxime Xiaomei I. LiuDionna J. GreenAndré Dallmann Original Research Article 14 November 2023 Pages: 69 - 78
How to Dose Vancomycin in Overweight and Obese Patients with Varying Renal (Dys)function in the Novel Era of AUC 400–600 mg·h/L-Targeted Dosing Tan ZhangElke H. J. KrekelsCatherijne A. J. Knibbe Original Research Article Open access 16 November 2023 Pages: 79 - 91
Population Pharmacokinetic/Pharmacodynamic Analysis of the Glucokinase Activator PB201 in Healthy Volunteers and Patients with Type 2 Diabetes Mellitus: Facilitating the Clinical Development of PB201 in China Ling SongFangrui CaoDongyang Liu Original Research Article 20 November 2023 Pages: 93 - 108
Digoxin Pharmacokinetics in Patients with Obesity Before and After a Gastric Bypass or a Strict Diet Compared with Normal Weight Individuals Kine Eide KvitneMarkus HovdIda Robertsen Original Research Article Open access 22 November 2023 Pages: 109 - 120
Impact of Key Components of Intensified Ceftaroline Dosing on Pharmacokinetic/Pharmacodynamic Target Attainment Iris K. MinichmayrSebastian G. WichaMarkus Zeitlinger Original Research Article Open access 26 November 2023 Pages: 121 - 131